Delivery Order SPE2DB20D3103-SPE2DB25FM5G5
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen subcutaneous injections to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,106.01 and an ultimate completion date of December 22, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the pharmaceutical product Cosentyx 300 mg in pre-filled syringes. It was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.92 fixed-price delivery order contract has a period of performance through July 31, 2023. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The $3,136.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through May 25, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 pen syringes. The contract has a ceiling value of $6,004.32 and runs through May 19, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg injection pens to the Defense Logistics Agency (DLA). The $36,519.25 fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has an ultimate completion date of December 27, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen injectors to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,521.95, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,493.13 contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the pharmaceutical product Cosentyx 300 mg dose-2 syringe, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price of $22,504.16 and a completion date of December 4, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Cosentyx medication (300mg dose) with a ceiling value of $16,339.26. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen medication to the Defense Logistics Agency (DLA). The contract, valued at $20,655.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...